Ilmarinen Mutual Pension Insurance Co lessened its holdings in shares of Morgan Stanley (NYSE:MS – Free Report) by 12.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 168,021 shares of the financial services provider’s stock after selling 23,013 shares during the quarter. Ilmarinen Mutual Pension Insurance Co’s holdings in Morgan Stanley were worth $31,601,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. E Fund Management Hong Kong Co. Ltd. boosted its holdings in Morgan Stanley by 171.8% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 818 shares of the financial services provider’s stock worth $154,000 after purchasing an additional 517 shares during the last quarter. Sumitomo Life Insurance Co. grew its holdings in Morgan Stanley by 0.7% during the third quarter. Sumitomo Life Insurance Co. now owns 19,856 shares of the financial services provider’s stock valued at $3,735,000 after purchasing an additional 144 shares during the period. Whittier Trust Co. grew its holdings in Morgan Stanley by 1.7% during the third quarter. Whittier Trust Co. now owns 22,312 shares of the financial services provider’s stock valued at $4,240,000 after purchasing an additional 366 shares during the period. TIAA Trust National Association increased its position in Morgan Stanley by 12.3% in the third quarter. TIAA Trust National Association now owns 2,929 shares of the financial services provider’s stock worth $551,000 after buying an additional 320 shares during the last quarter. Finally, Advisors Asset Management Inc. purchased a new stake in Morgan Stanley in the third quarter worth $48,055,000. Institutional investors and hedge funds own 84.19% of the company’s stock.
Insiders Place Their Bets
In other Morgan Stanley news, Director Judith Miscik sold 2,480 shares of the firm’s stock in a transaction dated Friday, November 6th. The stock was sold at an average price of $183.21, for a total value of $454,360.80. Following the sale, the director owned 64,215 shares of the company’s stock, valued at $11,764,830.15. This trade represents a 3.72% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.17% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
MS has been the topic of several research reports. TD Cowen lowered their target price on Morgan Stanley from $210.00 to $205.00 and set a “hold” rating on the stock in a research note on Thursday, October 15th. HSBC lifted their price objective on Morgan Stanley from $215.00 to $219.00 and gave the stock a “hold” rating in a report on Monday, September 28th. BMO Capital Markets lowered their price objective on Morgan Stanley from $215.00 to $210.00 and set an “outperform” rating on the stock in a research note on Monday, October 19th. Citigroup dropped their price objective on shares of Morgan Stanley from $210.00 to $190.00 and set a “neutral” rating on the stock in a report on Thursday, October 15th. Finally, UBS Group lifted their target price on shares of Morgan Stanley from $236.00 to $240.00 and gave the stock a “buy” rating in a research note on Monday, November 2nd. Two investment analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, thirteen have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Morgan Stanley has an average rating of “Moderate Buy” and an average target price of $214.81.
Check Out Our Latest Stock Analysis on Morgan Stanley
Morgan Stanley Price Performance
Shares of NYSE:MS opened at $165.38 on Friday. The company has a 50 day moving average of $189.02 and a 200 day moving average of $194.36. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 3.58. The stock has a market cap of $258.49 billion, a P/E ratio of 13.13, a P/E/G ratio of 1.24 and a beta of 1.23. Morgan Stanley has a 12 month low of $152.80 and a 12 month high of $232.25.
Morgan Stanley (NYSE:MS – Get Free Report) last announced its quarterly earnings results on Wednesday, October 14th. The financial services provider reported $3.03 EPS for the quarter, beating the consensus estimate of $2.93 by $0.10. The firm had revenue of $20.34 billion during the quarter, compared to the consensus estimate of $19.93 billion. Morgan Stanley had a net margin of 15.63% and a return on equity of 19.26%. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same period last year, the firm earned $2.80 EPS. As a group, sell-side analysts forecast that Morgan Stanley will post 12.83 EPS for the current fiscal year.
Morgan Stanley Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, November 13th. Investors of record on Friday, October 30th were given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.8%. The ex-dividend date was Friday, October 30th. Morgan Stanley’s payout ratio is presently 36.51%.
Recent Morgan Stanley Headlines
Here are a few of the latest headlines about MS:
- Positive Sentiment: The firm has launched four actively managed UCITS ETFs in Europe, extending its investment-product reach and potentially broadening access to international client flows. Article: Morgan Stanley (MS) Debuts Four Active UCITS ETFs In Europe
- Positive Sentiment: Morgan Stanley strategists are “max overweight” on U.S. and selected international equities for 2027, reflecting a favorable view of the AI-driven market outlook. This is a positive signal about the firm’s market perspective, rather than a direct update to Morgan Stanley’s own earnings. Article: Morgan Stanley Strategists Are "Max Overweight" on U.S. and Some International Stocks for 2027
- Neutral Sentiment: Broader market pressure was evident in a technology-led selloff, but the available reports do not establish that it directly caused Morgan Stanley’s share weakness. Article: QQQ is down 2.5% today, on MU stock price movement
About Morgan Stanley
Morgan Stanley is a global financial services company that provides investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individuals. Its Institutional Securities business offers services such as financial advisory, capital raising, sales and trading, and research. The company also provides financial planning, brokerage and banking services through its Wealth Management business, while its Investment Management business offers investment strategies and portfolio management to a range of clients.
Read More
- Five stocks we like better than Morgan Stanley
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.
